Recent Updates
Recently added Catalysts
CTOR

INDEX TO FINANCIAL STATEMENTS Page Audited Financial Statements of TenX Keane Acquisition: Report of Independent Registered Public Accounting Firm (PCAOB #688) F-2 Balance Sheet as of

Key Takeaway: TO FINANCIAL STATEMENTS Page Audited Financial Statements of TenX Keane Acquisition: Report of Independent Registered Public Accounting Firm (PCAOB #688) F-2 Balance Sheet as of October 18, 2022 F-3 Notes to Financial Statement F-4 OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING

Full Press Release Details

TO FINANCIAL STATEMENTS
Page
Audited Financial Statements of TenX Keane Acquisition:
Report of Independent Registered Public Accounting Firm (PCAOB #688) F-2
Balance Sheet as of October 18, 2022 F-3
Notes to Financial Statement F-4
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
the Shareholders and Board of Directors of
on the Financial Statement
have audited the accompanying balance sheet of TenX Keane Acquisition (the "Company") as of October 18, 2022, and the related
notes (collectively referred to as the "financial statement"). In our opinion, the financial statement presents fairly, in
all material respects, the balance sheet of the Company as of October 18, 2022, in conformity with accounting principles generally accepted
in the United States of America.
Paragraph - Going Concern
accompanying financial statement has been prepared assuming that the Company will continue as a going concern. As more fully described
in Note 1 to the financial statement, the Company's business plan is dependent on the completion of a business combination in less
than 12 months from the issuance date of the financial statement. If the initial business combination is not completed before this time,
the Company would be required to redeem all Ordinary Shares and would not have sufficient resources to continue operations. This
condition raises substantial doubt about the Company's ability to continue as a going concern. The financial statement does not
include any adjustments that might result from the outcome of this uncertainty.
financial statement is the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's
financial statement based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits
to obtain reasonable assurance about whether the financial statement is free of material misstatement, whether due to error or fraud.
The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part
of our audit, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing
an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.
audit included performing procedures to assess the risks of material misstatement of the financial statement, whether due to error or
fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statement. Our audit also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statement. We believe that our audit provides
a reasonable basis for our opinion.
have served as the Company's auditor since 2021.
October 18, 2022
ASSETS
Current assets:
Cash $ 758,979
Prepaid expenses 71,921
Total current assets 830,900
Prepaid expenses 29,141
Cash held in trust account 67,320,000
Total Assets $ 68,180,041
LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities:
Accrued liabilities $ 132,240
Over-allotment option derivative liability 25,906
Due to related party 248,784
Total Current Liabilities 406,930
Commitments and contingencies
Ordinary shares subject to possible redemption (6,600,000 shares at $10.20 per share) 67,320,000
Shareholders' Deficit:
Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding -
Ordinary shares, $0.0001 par value; 150,000,000 shares authorized; 242
2,416,000 shares issued and outstanding (1) (excluding 6,600,000 shares subject to possible redemption)
Additional paid-in capital 467,588
Accumulated deficit (14,719 )
Total Shareholders' Equity 453,111
T otal Liabilities and Shareholders' Equity $ 68,180,041
accompanying notes are an integral part of these financial statement.
to the financial statement
1 - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN
Keane Acquisition (the "Company") was incorporated in the Cayman Islands on March 1, 2021. The Company was formed for the
purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination
with one or more businesses (the "Business Combination").
Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early
stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth
of October 18, 2022, the Company had not commenced any operations. All activity for the period from March 1, 2021 (inception) through
October 18, 2022 relates to the Company's formation and the initial public offering ("Initial Public Offering"), which
is described below. The Company will not generate any operating revenues until after the completion an initial Business Combination,
at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial
Public Offering. The Company has selected December 31 as its fiscal year end.
registration statement for the Company's Initial Public Offering (the "Registration Statement") was declared effective
on October 13, 2022. On October 18, 2022, the Company consummated the Initial Public Offering of 6,600,000 units, including 600,000 additional
units issued pursuant to the partial exercise by the underwriter of its over-allotment option, ("Units" and, with respect
to the common stock included in the Units being offered, the "Public Shares"), generating gross proceeds of $66,000,000,
which is described in Note 3.
with the consummation of the Initial Public Offering and the sale of the Units, the Company consummated the private placement (the "Private
Placement") of 394,000 Units (the "Placement Units"), to the 10XYZ Holdings LP (the "Sponsor") at a price
of $10.00 per Placement Unit, generating total proceeds of $3,940,000.
of October 18, 2022, transaction costs amounted to $4,859,330 consisting of $1,320,000 of cash underwriting fees, non-cash
underwriting fees of $2,922,480 represented by the fair value of 297,000 shares issued to the underwriter and $616,850
of other offering costs. These costs were charged to additional paid-in capital or accumulated deficit to the extent additional
paid-in capital is fully depleted upon completion of the Initial Public Offering.
the closing of the Initial Public Offering on October 18, 2022, an amount of $67,320,000 ($10.20 per Unit) from the net proceeds of the
sale of the Units in the Initial Public Offering and the Private Placement (as defined in Note 4) was placed in the Trust Account. The
funds held in the Trust Account may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the
Investment Company Act of 1940, as amended (the "Investment Company Act"), with a maturity of 185 days or less or in any
open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7
of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination or (ii)
the distribution of the Trust Account, as described below.
Company's management has broad discretion with respect to the specific application of the net proceeds of the Proposed Public Offering
and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward
consummating a Business Combination. The stock exchange listing rules require that the Business Combination must be with one or more
operating businesses or assets with a fair market value equal to at least 80% of the assets held in the Trust Account (as defined below)
(excluding the taxes payable on the income earned on the Trust Account). The Company will only complete a Business Combination if the
post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise
acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under
the Investment Company Act of 1940, as amended (the "Investment Company Act"). There is no assurance that the Company will
be able to successfully effect a Business Combination. Upon the closing of the Proposed Public Offering, management has agreed that $10.00
per Unit sold in the Proposed Public Offering, including proceeds of the sale of the Private Placement Units, will be held in a trust
account (the "Trust Account") and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16)
of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as
a money market fund investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 of the Investment Company Act,
as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the funds
in the Trust Account to the Company's shareholders, as described below.
Company will provide the holders of the outstanding Public Shares (the "Public Shareholders") with the opportunity to redeem
all or a portion of their Public Shares either (i) in connection with a shareholder meeting called to approve the Business Combination
or (ii) by means of a tender offer in connection with the Business Combination. The decision as to whether the Company will seek shareholder
approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to
redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.20
per Public Share, plus any pro rata interest then in the Trust Account, net of taxes payable).
of the Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company's
liquidation, if there is a shareholder vote or tender offer in connection with the Company's Business Combination and in connection
with certain amendments to the Company's amended and restated certificate of incorporation (the "Certificate of Incorporation").
In accordance with the rules of the U.S. Securities and Exchange Commission (the "SEC") and its guidance on redeemable equity
instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of a company require common
stock subject to redemption to be classified outside of permanent equity. Given that the Public Shares will be issued with other freestanding
instruments (i.e., rights), the initial carrying value of ordinary shares classified as temporary equity will be the allocated proceeds
determined in accordance with ASC 470-20. The ordinary shares are subject to ASC 480-10-S99. If it is probable that the equity instrument
will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date
of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption
date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of
the instrument to equal the redemption value at the end of each reporting period. The Company has elected the immediate fair value
recognition method. The accretion will be treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence
of retained earnings, additional paid-in capital). While redemptions cannot cause the Company's net tangible assets to fall below
$5,000,001, the Public Shares are redeemable and will be classified as such on the balance sheet until such date that a redemption event
Last updated: Oct 18, 2022